Home / Anti-infectives / Amoxicillin and Beta-Lactamase Inhibitor
ATC J01CR02 · Antibacterials for Systemic Use
Amoxicillin and Beta-Lactamase Inhibitor shortage
As of 31 Oct 2026, Amoxicillin and Beta-Lactamase Inhibitor has a reported shortage in 2 of the 5 countries we track (Italy, Spain), covering 10 products.
Countries2/5
Products10packs or presentations
Short since11 Mar 20224.6 years ago
Earliest return31 Mar 2027company estimate
No return date8products
Main reasonIncreased demand
Timeline
ItalySpain
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | AMOXICILLINA E ACIDO CLAVULANICO ZENTIVA ITALIA | ZENTIVA ITALIA S.R.L. | 11 Mar 2022 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | AMOXICILLINA E ACIDO CLAVULANICO IBIGEN | IBIGEN S.R.L. | 30 Mar 2022 | not given | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | SAROMOX | HEXAL A/S | 9 Jun 2023 | not given | Increased demand Elevata richiesta |
| IT | ABIOCLAV | S.F. GROUP S.R.L. | 1 Jun 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | XINAMOD | PHARMACARE S.R.L. | 1 Apr 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | POSMOX | PHARMACARE S.R.L. | 1 Jun 2026 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale retail) |
| IT | AMOXICILLINA E ACIDO CLAVULANICO PENSA PHARMA | TOWA PHARMACEUTICAL S.P.A. | 1 Jul 2026 | 31 Mar 2027 | Increased demand Elevata richiesta |
| IT | AMOXICILLINA ACIDO CLAVULANICO TEVA | TEVA ITALIA S.R.L. | 14 Aug 2026 | not given | Increased demand Elevata richiesta |
| IT | AMOXICILLINA E ACIDO CLAVULANICO SANDOZ A/S announced | SANDOZ A/S | 14 Dec 2026 | not given | Manufacturing problem Problemi produttivi: ridotta disponibilità |
| ES | AMOXICILINA/ACIDO CLAVULANICO PENSA PHARMA 875 MG/125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | Towa Pharmaceutical S.A. | 29 Oct 2026 | 29 Oct 2027 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.